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The CD4/ T-cell-restricted recognition of the structural proteins in the JHM strain of MHV (JHMV) was compared between
two mouse strains. Following immunization with inactivated JHMV, all proteins elicited an immune response in both C57BL/
6 and BALB/c mouse strains, except the nucleocapsid (N) protein, which was not immunogenic in C57BL/6 mice. T-cell
lines and clones were derived from BALB/c mice immunized with UV-inactivated JHMV, to determine the epitope(s) for
CD4/ T cells. The N protein appears immunodominant, since all T-cell lines and clones derived therefrom recognized
this protein. To locate epitope-containing domains within the N protein, truncated N-protein fragments expressed in
vaccinia constructs were used to stimulate the T-cell clones. Five independent T-cell clones recognized three separate
N-protein domains: 1– 133, 134 – 249, and 250 –306. Since three of five clones recognized the last domain, its sequence
was studied in more detail by constructing overlapping synthetic peptides covering this region. A single epitope was
localized within the peptide comprising the N-protein residues 266– 279. Its restriction element was identified as I-Ed
using mAb to I-Ed and I-Ad. In addition, peptide N266 –279 contains the motif for binding to I-Ed. This peptide elicited
proliferative responses following immunization with JHMV, confirming its recognition in the complete virus. In addition,
peptide N266 – 279 was recognized by T-cell clones that express differences in cytokine profile as well as in TCR Vb
usage. q 1996 Academic Press, Inc.
INTRODUCTION protein, which, in addition to its structural role, plays a
number of important roles in viral replication, including
Mouse hepatitis virus (MHV) is a member of the coro- transcription (Baric et al., 1988; Nelson and Stohlman,
navirus group of animal viruses which are enveloped, 1993), and in pathogenesis (Nakanaga et al., 1986; 1987;
plus-stranded RNA viruses. Neurotropic strains of MHV Lecomte et al., 1987; Kyuwa and Stohlman, 1990; Stohl-
(JHM) have been described and are used to examine the man et al., 1993).
pathogenesis of acute and chronic infection of the central Infection with JHMV produces an acute encephalitis
nervous system (CNS) associated with demyelination with primary demyelination (Lampert et al., 1973, Weiner,
(Wege et al., 1982; Compton et al., 1993; Fazakerley and 1973). Survivors of the acute infection with either wild
Buchmeier 1993; Kyuwa and Stohlman, 1990). Virions type or variants of JHMV are unable to completely clear
contain three or four structural proteins. All strains have virus from the CNS, resulting in chronic demyelination
an envelope glycoprotein, designated the spike or S pro- (Erlich et al., 1987, Fazakerley and Buchmeier, 1993, Ky-
tein, which is the ligand for both neutralizing antibody uwa and Stohlman, 1990). Generally, little or no infectious
and carcinoembryonic antigen-related cellular receptors virus can be isolated (Stohlman and Weiner, 1981, Kno-
(Collins et al., 1982; Dveskler et al., 1993). The envelope bler et al., 1982). The similarities of chronic JHMV infec-
also contains an O-glycosylated protein, designated the tion, i.e., focal areas of primary demyelination, coupled
M protein, which appears to function as a matrix protein with the inability to recover infectious virus from the ma-
(Lai, 1990), and a recently described minor envelope pro- jority of infected mice, suggest parallels to the human
tein, the small membrane or sM protein whose function demyelinating disease multiple sclerosis.
is unclear (Yu et al., 1994). In addition, some strains, During acute JHMV infection, the host’s antiviral im-
including JHM, have a fourth envelope glycoprotein, the mune response determines not only the clinical outcome,
hemagglutinin esterase or HE protein (Yokomori et al., but appears to play a critical role in establishing chronic
1990). Although not required for viral adsorption or repli- infections (Fazakerley and Buchmeier, 1993; Kyuwa and
cation in vitro, the HE protein appears to play a role in the Stohlman, 1990). For example, immunocompromised
pathogenesis of virus-induced CNS disease (Yokomori et hosts are unable to clear virus and succumb to a lethal
al., 1992). Internally, virions contain a plus-sensed RNA panencephalitis (Kyuwa and Stohlman, 1990; Sorenson
genome of approximately 31 kb associated with the nu- et al., 1987; Wang et al., 1990; Weiner, 1973). Protection
cleocapsid (N) protein, which together form a helical nu- from lethal infection, but not necessarily from virus-in-
duced demyelination, can be achieved via manipulationscleocapsid (Lai, 1990). The N protein is a basic phospho-
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of the antiviral immune response (Kyuwa and Stohlman, monolayer demonstrated 95% fusion (approximately 20
hr incubation). The JHMV-DL variant, used as a source1990). In contrast to virus infections in which a single
major effector mechanism predominates, JHMV infection of antigen, was obtained by washing the infected DBT-
cell monolayer with PBS and scraping the cells off thecan be modulated by cell-mediated immunity, as well as
both neutralizing and nonneutralizing antibodies (Buch- plate. Cells from each plate were resuspended in 4 ml
PBS, sonicated, and the cell debris was removed by cen-meier, et al., 1984; Fleming et al., 1988; Lecomte et al.,
1987; Nakanaga et al., 1986). Both virus-specific CD4/ T trifugation. Clarified lysates yield approximately 8 1 107
PFU/ml. Virus in the lysates was inactivated by UV irradi-cells and CD8/ cytotoxic T lymphocytes (CTL) provide
protection from acute disease (Kyuwa and Stohlman ation and complete inactivation was verified on DBT-
cell monolayers. Uninfected DBT-cell monolayers were1990; Stohlman et al., 1986; Sussman et al., 1989; Wege
et al., 1993; Yamaguchi et al., 1991; Zimprich et al., 1991). processed similarly to serve as control antigen. Viral
preparations were stored at 0707 prior to use.Since CTL are only partially responsible for viral clear-
ance from the CNS (Stohlman et al., 1995) and protection
Recombinant vaccinia virus constructsis also partially mediated by JHMV-specific CD4/ T cells,
we set out to characterize the CD4/ T-helper cell re-
Derivation of recombinant vaccinia viruses expressing
sponse. A vigorous CD4/ T-cell response to the N protein
entire viral N, S, M, or HE proteins, or carboxy-terminal
is elicited in Lewis rats (Wege et al., 1993), which pro-
deletions of the N protein, designated vJN133 (for resi-
vides protection. The N epitope providing a protective
dues 1 to 133), vJN249, vJN306, and vJN378, has been
response in RT1 rats was located at the carboxy terminus
previously described (Stohlman et al., 1992, 1993; Berg-
of the N protein (Wege et al., 1993). By contrast only the
mann et al., 1993) and were kindly provided by Drs. S.
S and M proteins were recognized by murine CD4/ T
Stohlman and C. Bergmann. The JHMV proteins ex-
cells derived from C57BL/6 (H-2b) mice (Mobley et al.,
pressed by the recombinant vaccinia-virus constructs
1992). Only a single epitope, encompassing residues
were prepared as UV-inactivated lysates of DBT cells,
128–147 within the M protein, has been determined for
as described above for the DL variant, except that the
mice (Xue et al., 1995). An epitope on the S protein was
infection of the DBT cells was performed at an m.o.i. of
also reported recently (Heemskerk et al., 1995). We pre-
5, and the incubation time was 2 days. As control antigen,
viously mapped the antigenic domains recognized by a
a vaccinia-virus construct expressing b-galactosidase
panel of BALB/c-derived N protein-specific mAb (Stohl-
(vSC8) was processed similarly. Mice were immunized
man et al., 1994) and undertook the present study to
intraperitoneally (i.p.) with 100 ml of undiluted UV-inacti-
determine the extent of CD4/ T cell reactivity in H-2d
vated lysate.
mice. The data demonstrate that H-2d mice respond to
all four virus structural proteins, including the N protein T cell lines and clones
which does not induce a CD4/ T cell response in H-2b
mice. At least three antigenic domains within the N pro- Spleen cells were obtained from mice immunized i.p.
10 days previously with 100 ml undiluted UV-inactivatedtein were identified, one of which was mapped to resi-
dues 266–279. Our results suggest that in contrast to H- JHMV (UV-JHMV). Lines and clones were derived and
maintained as previously described (van der Veen et al.,2b mice, the N protein is immunologically important and
possibly immunodominant in BALB/c mice. 1990). Briefly, spleen cells (4 1 106 cells/ml) were stimu-
lated with UV-JHMV at a final dilution of 1:200. Five inde-
pendent lines were established by restimulation at 5 1METHODS
105 cells/ml every 10–14 days, using g-irradiated synge-
Mice neic spleen cells at 4 1 106 cells/ml as a source of
antigen-presenting cells, and UV-JHMV as antigen. AfterMale BALB/cByJ and C57BL/6 mice were obtained
three or four rounds of stimulation, clones were isolatedfrom the Jackson Laboratory (Bar Harbor, Maine) and
from three lines by limiting dilution in 96-well microtiterused at 6–8 weeks of age. All groups of mice were
plates, in the presence of UV-JHMV, irradiated syngeneicseronegative for MHV upon arrival.
spleen cells and 10% supernatant from concanavalin A-
stimulated rat spleen cells, as described (van der VeenVirus
et al., 1990). The T-cell clones were positive for CD4 (PE-
labeled anti-CD4 H129-19; Pharmingen, San Diego, CA)A previously described plaque variant of JHMV was
used in these studies (Stohlman et al., 1982). The JHMV- and for ab-TCR (FITC-labeled anti ab TCR H57-597;
Pharmingen), as determined by FACS. T-cell stimulationDL variant was propagated in DBT-cell monolayers as
described (Woodward et al., 1984). Briefly, confluent DBT assays were performed in 96-well microtiter plates. T-
cell clones (21 104 cells/well) or lines (51 104 cells/well)cells in 5 1 150-cm tissue culture plates (approximately
2 1 107 cells per plate) were infected at a multiplicity were cultured with irradiated syngeneic spleen cells (106
mononuclear cells/well) in 200 ml, in the presence orof infection (m.o.i.) of 0.02 and incubated until the cell
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absence of antigen. Similarly, spleen or lymph node cells
were assayed for antigen-specific proliferation at 8 1 105
cells/well. After 48 hr incubation, either the supernatants
were harvested and assayed for cytokines or cultures
were pulsed with 1 mCi/well of [3H]thymidine (ICN, Costa
Mesa, CA) and incubated for an additional 16 hr, after
which the cells were harvested onto fiberglass filters,
and tritium incorporation measured in a scintillation
counter. Cytokines in supernatants were identified by
a sandwich ELISA. For IFN-g, supernatants from clone
HB170 (DNAX, Palo Alto, CA) and biotinylated antibodies
from clone XMG1.2 (Pharmingen) were used. IL-4 was
measured using mAb BVD4-1D11 (Pharmingen) as cap-
ture Ab and biotinylated mAb BVD6-24G6 (Pharmingen)
for detection. IL-10 was measured using mAb JES5-2A5
(Pharmingen) for capture and mAb SXC-1 for detection.
FIG. 1. Response of T cell lines derived from virus-immunized mice
Synthetic peptides to viral proteins. After intraperitoneal immunization of BALB/c mice with
UV-inactivated JHMV, the spleen cells were cultured with UV-JHMV as
Synthetic peptides spanning N protein residues 251– antigen and restimulated every 10–14 days. The proliferation of the
cell lines was tested in the presence of individual JHMV proteins, in306, each 14 amino acids long and overlapping by 10
the form of UV-inactivated DBT cell lysates containing vaccinia con-amino acids, were purchased from Chiron Mimotopes
structs at a final dilution of 1:100. The proliferation is indicated as total(Clayton, Australia). Purity as well as quantity was as-
incorporated [3H]thymidine. Background incorporation in the absence
sessed by the supplier for three control peptides by of antigen was approximately 103 cpm. Results from one cell line are
HPLC and amino acid analysis. Peptides were solubi- shown; other unrelated cell lines showed similar characteristics.
lized at 1 mM in DMSO and diluted in PBS for proliferation
assays. Peptide N266–279 was prepared in bulk by the
mice; however, the predominance of N-protein reactiveMicrochemical Core Laboratory, USC Norris Comprehen-
T cells propagated in vitro suggests a form of dominancesive Cancer Center, on an Applied Biosystems Model
of the response to the N protein in BALB/c mice.430A synthesizer. Amino acid analysis and analytical
HPLC confirmed the correct composition and purity.
T-helper cell epitopes on the N protein
RESULTS To locate potential CD4/ T-cell domains within the N
protein, lysates of DBT cells were prepared followingImmunogenicity of JHMV proteins
infection with a panel of recombinant vaccinia viruses
expressing carboxy-terminal truncations of the N proteinTo examine the immunogenicity of individual JHMV
structural proteins, T-cell responses were examined in (Stohlman et al., 1992). The T-cell clones were tested for
their ability to proliferate in response to lysates con-mice previously immunized with UV-JHMV. T-cell stimula-
tion was detected as IFN-g production, induced by JHMV taining the truncated N-protein products. One clone, des-
ignated 8D6, recognized lysates containing all carboxy-or the S, M, HE, or N proteins as antigens. The presence
of a response to all four structural proteins in BALB/c terminal truncations, including the smallest fragment,
encompassing residues 1 to 133 (Fig. 2A). These datamice contrasted with the absence of a response to the
N protein in C57BL/6 mice, as described before (Mobley suggest that at least one epitope is located within a
domain encompassed by amino acids 1–133. Clone 7D3et al., 1992) (results not shown).
To examine the immune response to the viral structural recognized N-protein fragments encompassing residues
1–249 and all longer fragments, but not residues 1–133proteins in BALB/c mice in more detail, T-cell lines were
established from immunized mice, using UV-JHMV as (Fig. 2B), suggesting that clone 7D3 recognizes a domain
within the amino acid sequence 134–249. Clone 4C4 didantigen to minimize selective pressure. All four low-pas-
sage T-cell lines studied responded to both JHMV and not recognize N-protein fragments 1–249 or shorter, but
proliferated in response to lysates containing fragmentto the N protein (Fig. 1). None of the lines proliferated in
response to lysates containing the M, S, or HE proteins 1–306 and longer fragments (Fig. 2C), suggesting that
the epitope recognized by this clone is contained withinor from control-infected cells. The same response pattern
was obtained with a series of T-cell clones derived from the sequence 250–306. Thus, analysis of these clones
indicates that at least three distinct CD4/ T cell epitopesthese lines (data not shown). These results suggest that
T cells with specificity for each of the JHMV structural are present within the N protein, i.e., contained within
residues 1–133, 134–249, and 250–306. The prolifera-proteins are initially induced upon immunization of H-2d
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To ensure that peptide N266–279 represents an immu-
nogenic JHMV epitope, draining lymph node cells from
immunized BALB/c mice were tested for proliferative re-
sponses to both JHMV and the N266–279 peptide. Immu-
nization with JHMV indeed induced N266–279-specific
T-cell responses (Fig. 4), confirming that this sequence
contains a JHMV-specific T-cell epitope.
The restriction element that presents peptide N266–
279 was investigated using antibodies specific for I-Ad
(34-5-3; Ozato et al., 1982) or I-Ed (14-4-4; Ozato et al.,
1980). As shown in Fig. 5, anti I-E antibodies blocked the
stimulation of clone 4B6 in a concentration-dependent
fashion, whereas I-A-specific antibodies did not. Concen-
trations of I-A antibodies as high as 1:20 did not inhibit
the stimulation of clone 4B6 (not shown). On the contrary,
the T-cell stimulation increased somewhat in the pres-
ence of I-Ad antibodies. Similar results were obtained
with clone 4C4 (results not shown). Since both antibodies
were of the IgG2a isotype, they functioned as internal
control antibodies. The I-Ed-specific antibodies did not
inhibit the stimulation of a control T-cell clone, specific
for proteolipid protein of myelin, and derived from SJL
mice.
Well-defined motifs for peptides that bind to I-Ed or
FIG. 2. Specificity of JHMV-specific clones for different domains on
the N protein. CD4/ T-cell clones were stimulated in the presence
of C-terminally truncated fragments of the N protein, expressed as a
construct in vaccinia, and UV-inactivated. As control antigen, a vaccinia
construct with an unrelated protein (b-galactosidase) was used. (A)
clone 8D6; (B) clone 7D3; (C) clone 4C4. The antigen-specific thymidine
incorporation (total incorporation minus control antigen-induced incor-
poration) is shown.
tive responses of two additional clones (4B6, 7D5) both
mapped to the domain encompassing residues 250–306
(not shown). Since three of five clones recognized this
domain, peptides containing 14 amino acids, which over-
lapped by 10 residues, were synthesized homologous to
domain 250–306 to determine the existence of single or
multiple epitopes within this region. Analysis of this panel
of peptides using the three clones that tentatively
mapped to residues 250– 306 demonstrated that all three
clones recognized a peptide comprising amino acids
FIG. 3. Peptide specificity of N250–306-specific T-cell clones. Over-266–279 (KILNKPRQKRTPNK) (Fig. 3). Neither of the par-
lapping synthetic peptides were used as antigen for the stimulation oftially overlapping flanking peptides 261–274 or 270–283
clone 4B6. Results with four partially overlapping peptides are shown
were recognized by any of the three clones, indicating as antigen-specific thymidine incorporation (total incorporation minus
that these overlapping peptides lack critical epitope resi- incorporation in the absence of peptides). The two other N250–306-
specific clones (4B6, 7D5) showed an identical recognition pattern.dues, located within sequences 266–269 and 275–279.
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FIG. 4. Immunogenicity of peptide N266–279. BALB/c mice were immunized subcutaneously with 100 ml UV-JHMV emulsified with 100 ml complete
Freund’s adjuvant. Ten days later, draining lymph node cells were cultured at 8 1 105 cells/well with UV-JHMV or peptide N266–279 (N pep) at
varying concentrations. Cultures were pulsed as described under Methods, and results were depicted as antigen-specific thymidine incorporation
(total incorporation minus incorporation in the absence of peptides). Similar results were obtained in two separate experiments.
I-Ad have been described (Sette et al., 1989). Peptide T-cell clones specific for JHMV protects against death
without altering the kinetics of viral replication (StohlmanN266–279 contains the motif for binding to I-Ed, which
consist of a basic amino acid on position 1, 2, or 3 (K270), et al., 1986). These clones induced encephalomyelitis
which was accompanied by demyelination. By contrast,another basic residue on position 4 (R272), followed by
an uncharged residue (Q273) and again a basic residue the ability to partially restrict viral replication appears to
be a function of other JHMV-specific CD4/ T-cell clones(K274). As expected, the motif for I-Ad was not present
within N266–279. which also protect from lethal challenge (Yamaguchi et
al., 1991). Whether this effect on viral replication is due
Characterization of N266–279-specific T-cell clones to cytokine secretion or a direct cytotoxic attack on MHC
class II-positive cells is not clear. Both anti-viral antibod-The cytokine-secretion pattern of two of the N266 –
ies and CD8/ CTL also protect from lethal infection279-specific T-cell clones reflected a typical Th1 pattern
(Buchmeier et al., 1984). The passive transfer of neutraliz-as demonstrated in Table 1 for clone 4B6. By contrast,
ing mAb not only protects mice from acute infection butone clone (designated 4C4) expressed a Th0-like cyto-
eliminates the chronic phase of disease. However, recentkine-secretion pattern, producing both the Th2 cytokines
analysis of the kinetics of neutralizing-antibody inductionIL-4 and IL-10, in addition to the Th1 cytokine IFN-g,
relative to the clearance of virus from the CNS suggestsbut not IL-2. To determine if the divergence in cytokine
that virus is cleared prior to the detection of serum neu-secretion was reflected in differential TCR utilization, the
tralizing antibodies (S. A. Stohlman, personal communi-TCR of both clones 4B6 and 4C4 was sequenced as
cation). Although depletion of CD8/ T cells inhibits viraldescribed previously (van der Veen et al., 1995). The TCR
clearance (Williamson and Stohlman, 1990), the adoptiveVb usage of these clones was different (see Table 1), as
transfer of CTL provides only partial, but not complete,was the Jb usage and the D-region sequence (data not
reduction in virus from the CNS (Yamaguchi et al., 1991).shown). Besides confirming the clonality of the T-cell
The related MHV-A59 strain, which lacks the major H-2b-clones, these results demonstrate that the epitope N266–
restricted CTL epitope by virtue of a large natural deletion279 induces different subsets of T-helper cells with vari-
within the S protein (Luytjes et al., 1988) induces CD4/able TCR usage.
T cells capable of lysing targets in vitro and protecting
mice from acute infection (Wijburg et al., 1996). TheseDISCUSSION
data suggest that the CD4/ T-cell response following
Various immune effector mechanisms appear to be JHMV infection plays an important role in pathogenesis.
involved in immunity induced by JHMV and the protection The present studies were initiated to begin the charac-
accompanied by viral clearance or persistence. CD4/ T terization of the CD4/ T-cell response to JHMV in BALB/
cells appear to enter the CNS following JHMV infection c mice. Studies in other systems demonstrate that each
prior to the entry of CD8/ T cells (Williamson et al., 1991) viral protein may play a unique role in the overall virus-
and participate either directly or indirectly in the reduc- specific immune response. For example, immunogenicity
tion of infectious virus (Williamson, 1992; Pearce et al., of viral proteins varies between mouse strains with differ-
ent MHC haplotypes (Kulkarni et al., 1992). In addition,1994). For example, the adoptive transfer of some CD4/
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infection, whereas C57BL/6 mice can be protected by
the HE or M, but not the N or S proteins. An immune
response to the N protein is absent in C57BL/6 mice, but
as demonstrated here, is strongly induced in BALB/c
mice. In vitro culture of T cell lines from BALB/c mice
results in a clear dominance of immune cells recognizing
the N protein. Whether this is simply a reflection of the
quantitative dominance of the N protein in JHMV prepara-
tions is unknown.
Analysis of T-cell clones indicates the existence of at
least three separate CD4/ T-cell epitopes within the N
protein, i.e., domains 1–133, 134–249, and 250–306. In
contrast, upon analysis of the N protein-specific re-
sponse in Lewis rats, a single epitope was found on the
C-terminal one-third of the protein (Wege et al., 1993).
This portion of the protein also contains few antibody-
binding epitopes, since only 2 of 13 monoclonal N-spe-
cific antibodies mapped to the C-terminal third of the
protein (Stohlman et al., 1994). A CD8/ T-cell epitope on
the N protein has been located on residues 318–326
(Bergmann et al., 1993) and therefore does not overlap
with any of the CD4/ T-cell epitopes described here. For
five clones that recognized the N protein, a restricted
domain could be positively identified as containing an
epitope. Three of the five clones recognized domain
N250–306, and since this appeared an important immu-
nogenic site, overlapping peptides were synthesized cov-
ering this region. All three clones strongly recognized
FIG. 5. Restriction element for peptide N266–279. T-cell clone 4B6 peptide 266–279. The partially overlapping peptides
was stimulated using peptide N266–279 as antigen at 1 mM in the
261–274 and 270–283 were not recognized, suggestingpresence of mAb 14-4-4 (anti I-Ed) or 34-5-3 (anti I-Ad) at different dilu-
that both the N- and C-terminal four or five residues ontions. Cultures were incubated and pulsed as described under Methods
and depicted as total thymidine incorporation{SD from triplicate wells. peptide 266–279 contained amino acids essential for
Antigen-nonspecific incorporation was 2 1 103 cpm. Similar results recognition. The exact fine specificity within this epitope
were obtained in two additional experiments. remains to be elucidated using amino acid substitutions.
No variability in the N266–279 sequence exists among
several different MHV strains (Parker and Masters, 1990),immunization with some but not all viral proteins induces
a protective response (Wesseling et al., 1993). JHMV in- suggesting that it is confined to a conserved region.
Therefore, this epitope may also be involved in the im-fection of C57BL/6 mice demonstrated an additional as-
pect of the antiviral immune response. In persistently mune response to hepatotropic MHV infections in H-2d
mice.infected C57BL/6 mice, the CD4/ T-cell response to
JHMV is restricted to the epitopes within the S structural
protein, whereas in immunized and protected mice, CD4/
TABLE 1T-cell immunity to both M and S proteins can be detected,
suggesting that immunity to M is important in the protec- TCR Vb Usage and Cytokine Production by Two T-cell Clones That
tion (Mobley et al., 1992). By contrast, T-helper cell re- Are Both Specific for Peptide 266–279 of the N Protein
sponses to the N protein coincided with early, acute
IL-4 IL-10 IFN-gdisease in JHMV-infected rats, while CD4/ T-cell immu-
Vb (ng/ml) (ng/ml) (U/ml) IL-2nity to the S protein was only detected in rats with a
later onset of disease, suggesting a protective role for 4B6 10 0(.5) 0(.3) /(5) /
immunity to the S protein (Korner et al., 1991). These data 4C4 6 /(10) /(10) /(4) 0
suggest that differential CD4/ T-cell responses may be
Note. Cytokines were induced by stimulation of the clones usingassociated with both protection from acute disease and
immobilized anti-CD3 antibodies and measured in the cell supernatantspersistence of JHMV in the CNS.
by ELISA (IL-4, IL-10, IFN-g) or by stimulation of HT-2 cell line (IL-2) in
Studies in progress indicate that preimmunization with the presence of antibodies to IL-2 or IL-4, as described (van der Veen
the N, as well as HE proteins, but not with the M or S et al., 1993). TCR Vb genes were sequenced as described (van der
Veen et al., 1995).proteins, protects BALB/c mice against a lethal JHMV
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molecular pathogenesis of coronavirus. Lab. Animal Science 43, 15–The restriction element for peptide 266–279 was iden-
28.tified as I-E, since antibodies to I-Ed but not I-Ad inhibited
Dveskler, G. S., Dieffenbach, C. W., Cardellichio, C. B., McCuaig, K.,
the stimulation of clones 4B6 and 4C4. Indeed, peptide Pensiero, M. N., Jiang, G.-S., Beauchemin, N., and Holmes, K. V.
N266–279 contains the I-E binding motif (which consists (1993). Several members of the mouse carcinoembryonic antigen-
related glycoprotein family are functional receptors for the coronavi-of the following classes of amino acids: basic-X (n 
rus mouse hepatitis virus-A59. J. Virol. 67, 1–8.0–2)-basic-uncharged-basic) as follows: K-(X)-R-Q-K on
Erlich, S., Fleming, J., Stohlman, S., and Weiner, L. (1987). Experimentalresidues 270–274. This sequence forms the core of pep-
neuropathology of remote infection with a JHM virus variant (DS).
tide 266–279. The flanking regions of peptide 266–279 Arch Neurol. Sci. 44, 839–842.
also contain at least one crucial residue, since overlap- Fazakerley, J. K., and Buchmeier, M. J. (1993). Pathogenesis of virus-
induced demyelination. Adv. Virus Res. 42, 249–324.ping peptides lacking the flanking residues 266–270 or
Fleming, J. O., Shubin, R. A., Sussman, M. A., Casteel, N., and Stohlman,274–279 did not stimulate the T-cell clones and possibly
S. A. (1988). Monoclonal antibodies to the matrix (E1) glycoproteincontain TCR-binding residues.
of mouse hepatitis virus protect mice from encephalitis. Virology 168,
All BALB/c-derived T-helper clones, with a single ex- 162–167.
ception, expressed a Th1 phenotype, i.e., secretion of IL- Heemskerk, M. H. M., Shoemaker, H. M., DeJong, I., Schijns, V. E. C. J.,
Spaan, W. J. M., and Boog, C. J. P. (1995). Differential activation of2 and IFN-g, but not IL-4 or IL-10. Clone 4C4 produced
mouse hepatitis virus-specific CD4/ cytotoxic T cells is defined bya Th0-type of cytokine secretion pattern, namely IL-4, IL-
peptide length. Immunology 85, 517–522.10, and IFN-g. The TCR usage of the Th1 clone 4B6 and
Knobler, R. L., Lampert, P. W., and Oldstone, M. B. (1982). Virus persis-
the Th0 clone 4C4, both specific for peptide 266–279, tence and recurring demyelination produced by a temperature-sensi-
was variable: the Vb and Jb usage was different, as were tive mutant of MHV-4. Nature 298, 279–280.
Korner, H., Schliephake, A., Winter, J., Zimprich, F., Lassmann, H., Sedg-the D-region sequences. These data support the concept
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